Selection of Biologics for Type 2-High Asthma
- PMID: 31106563
- PMCID: PMC6775871
- DOI: 10.1164/rccm.201904-0763LE
Selection of Biologics for Type 2-High Asthma
Comment in
-
Reply to Yilmaz: Selection of Biologics for Type 2-High Asthma.Am J Respir Crit Care Med. 2019 Sep 15;200(6):791-792. doi: 10.1164/rccm.201904-0898LE. Am J Respir Crit Care Med. 2019. PMID: 31106571 Free PMC article. No abstract available.
Comment on
-
Role of Biologics in Asthma.Am J Respir Crit Care Med. 2019 Feb 15;199(4):433-445. doi: 10.1164/rccm.201810-1944CI. Am J Respir Crit Care Med. 2019. PMID: 30525902 Free PMC article. Review.
References
-
- Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, et al. Omalizumab effectiveness by biomarker status in patients with asthma: evidence from PROSPERO, a Prospective Real-World Study. J Allergy Clin Immunol Pract. 2019;7:156–164, e1. - PubMed
-
- GINA. Adolescent and adults with difficult-to-treat and severe asthma. 2018 [accessed 2018 Mar 4]. Available from: www.ginaasthma.org.